Loading data for CERT — first visit, this takes a few seconds.
Certara, Inc. (CERT)
NasdaqGS: CERT
· 实时价格 · USD
7.63
-0.11 (-1.42%)
收盘价： Sep 10, 2026, 3:59 PM
股价、关键数字和最新消息，都在这一页。
Certara, Inc.（CERT）股价、分析与数据
-1.42% (1D)
| 买价 | 7.66 |
| 市值 | 1.16B |
| 营收（TTM） | 422M |
| 净利润（TTM） | -22.5M |
| 1.41 | |
| -0.14 | |
| n/a | |
| 19.52 | |
| 市净率（TTM） | 1.20 |
| 市销率（TTM） | 2.76 |
| 财报日期 | Nov 5, 2026 |
| 卖价 | 9.67 |
| 成交量 | 1,462,915 |
| 20日均量 | 3,792,993 |
| 开盘价 | 7.71 |
| 前收盘价 | 7.74 |
| 日内区间 | 7.50 - 7.72 |
| 52周区间 | 4.45 - 13.88 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 CERT
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic bios...
公司完整简介财报意外
Certara 已于 Aug 4, 2026 发布季度财报：
- 营收为 $93.27M 低于预期 $0, ， 0.99% 同比增长.
- 每股收益为 0.08 低于预期 -0.01, ， 14.29% 同比增长.
第 1 页，共 2 页